Skip to main content
About
Contact
Subscribe
e-Edition
Make Home Page
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Twitter
Toggle navigation
Site search
Search
Home
Contact Us
Advertise
Subscription Services
Promote Your Event
Submission Forms
News
Local News
National
World
Archives
Sports
Local Sports
National Sports
Business
Local Business
National Business
Technology
Markets & Stocks
Opinion
Columns
Editorials
Letters To The Editor
Polls
Thumbs
A & E
Local Entertainment
Art Scene
Music Scene
Theatre Scene
Book Reviews
Movie Reviews
TV Listings
Local Events
What To Do
Life
Health
Travel
Oddities
Food Scene
Community Directory
Community Service
Restaurant Guide
Rescue Me
Other
Specials
Entertainment Now
Spring Wellness
Home & Garden
Home Improvement
Home & Realty
Horizons
Outdoor Guide
Progress
Women
Classifieds
Place Ad
Careers
Tenders
Weather
Obituaries
Parcel Services
2022 Readersâ Choice Awards
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Agenus Inc
(NQ:
AGEN
)
2.560
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EST, Feb 7, 2023
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
0
Open
2.560
Bid (Size)
2.530 (1)
Ask (Size)
2.600 (7)
Prev. Close
2.560
Today's Range
2.560 - 2.560
52wk Range
1.250 - 3.370
Shares Outstanding
304,811,685
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
Top News
More News
Agenus to Participate in February Investor Conferences
January 26, 2023
From
Agenus Inc.
Via
Globe NewsWire
Agenus Presents Clinical Data Demonstrating Durable Responses For Colorectal Cancer Candidate
January 23, 2023
Via
Benzinga
Performance
YTD
+6.67%
+6.67%
1 Month
+8.02%
+8.02%
3 Month
+14.80%
+14.80%
6 Month
N/A
N/A
1 Year
+2.40%
+2.40%
More News
Read More
Agenus Presents Clinical Data Demonstrating Durable Responses of Botensilimab/Balstilimab Combination in Metastatic Microsatellite Stable Colorectal Cancer at ASCO GI
January 23, 2023
From
Agenus Inc.
Via
Globe NewsWire
Looking Into Agenus's Return On Capital Employed
December 05, 2022
Via
Benzinga
Why Shares of Agenus Rose 12.5% on Friday
December 02, 2022
Via
The Motley Fool
Agenus (AGEN) Q3 2022 Earnings Call Transcript
November 08, 2022
Via
The Motley Fool
VBI Vaccines, Agenus Ink Partnership For Combination Brain Cancer Therapy
October 12, 2022
Via
Benzinga
Agenus to Participate at B Riley Securities’ 2023 Virtual Oncology Conference
January 10, 2023
From
Agenus Inc.
Via
Globe NewsWire
Benzinga's Top Ratings Upgrades, Downgrades For December 22, 2022
December 22, 2022
Via
Benzinga
Agenus to Present Botensilimab Data at Late-Breaking Oral Session at ASCO-GI
December 21, 2022
From
Agenus Inc.
Via
Globe NewsWire
7 Hot Stocks to Book Profits In Before 2023
December 19, 2022
Via
InvestorPlace
Agenus Data at CTOS 2022 Highlight Durable Clinical Responses of Botensilimab / Balstilimab Combination in Advanced Sarcoma
November 17, 2022
From
Agenus Inc.
Via
Globe NewsWire
Agenus to Participate at 5th Annual Evercore ISI HealthCONx Conference
November 16, 2022
From
Agenus Inc.
Via
Globe NewsWire
Why Infinity Pharmaceuticals Shares Tumbled Around 38%; Here Are 79 Biggest Movers From Yesterday
November 15, 2022
Via
Benzinga
Miniso Group, Monday.com And Other Big Gainers From Monday
November 15, 2022
Via
Benzinga
Why Opiant Pharmaceuticals Shares Are Trading Higher By 115%? Here Are 53 Stocks Moving In Monday's Mid-Day Session
November 14, 2022
Via
Benzinga
Agenus Data at SITC 2022 Highlight Durable Responses of Botensilimab / Balstilimab Combination in Nine Different Treatment-Resistant Cancers
November 14, 2022
From
Agenus Inc.
Via
Globe NewsWire
360 DigiTech, HUTCHMED And Some Other Big Stocks Moving Higher In Today's Pre-Market Session
November 14, 2022
Via
Benzinga
Agenus Provides Corporate Update and Third Quarter 2022 Financial Report
November 08, 2022
From
Agenus Inc.
Via
Globe NewsWire
10 Best Medical Stocks Under $5
October 29, 2022
Via
Talk Markets
Agenus to Provide Corporate Update and Third Quarter 2022 Financial Report
October 25, 2022
From
Agenus Inc.
Via
Globe NewsWire
GSK’s older adult RSV vaccine candidate, containing Agenus’ QS-21 STIMULON™, shows 94.1% reduction in severe RSV disease and overall vaccine efficacy of 82.6% in pivotal trial
October 13, 2022
From
Agenus Inc.
Via
Globe NewsWire
VBI Vaccines and Agenus Announce Collaboration to Evaluate VBI-1901 in Combination with Anti-PD-1 Balstilimab in a Phase 2 Study in Primary Glioblastoma Patients
October 12, 2022
From
Agenus Inc.
Via
Globe NewsWire
12 Health Care Stocks Moving In Monday's After-Market Session
October 10, 2022
Via
Benzinga
Why Cyclerion Therapeutics Shares Traded Lower By Around 38%; Here Are 70 Biggest Movers From Yesterday
October 07, 2022
Via
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.